Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders

Abnormal neural oscillations and synchrony in schizophrenia

Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120 · see citing works

The mGluR theory of fragile X mental retardation

Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · see citing works

A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome

Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558 · see citing works

Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice

Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · see citing works

Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins

Tu, J. C., Xiao, B., Naisbitt, S. R., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80810-7 · Cited by 1,047 · see citing works

The gamma cycle.

Fries, P., Nikolić, D., & Singer, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.05.005 · Cited by 1,044 · see citing works

Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism

Schneider, T., & Przewłocki, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300518 · Cited by 959 · see citing works

Autism‐like behavioral phenotypes in BTBR T+tf/J mice

McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812 · see citing works

Postnatal neurodevelopmental disorders: meeting at the synapse?

Zoghbi, H. Y. (2003) · Science · doi:10.1126/science.1089071 · Cited by 691 · see citing works

Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication

Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D. L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A. M., Scattoni, M. L., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-15 · Cited by 584 · see citing works

Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation

Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.589 · Cited by 563 · see citing works

Mouse Behavioral Assays Relevant to the Symptoms of Autism*

Crawley, J. N. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00096.x · Cited by 541 · cited 1× · see citing works

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · see citing works

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism

Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., & Pevsner, J. (2001) · Neurology · doi:10.1212/wnl.57.9.1618 · Cited by 518 · see citing works

Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome

McBride, S. M. J., Choi, C. H., Wang, Y., Liebelt, D. A., Braunstein, E. M., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.038 · Cited by 473 · see citing works

Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior

Blundell, J., Blaiss, C. A., Etherton, M. R., Espinosa, F., Tabuchi, K., Walz, C., Bolliger, M. F., Südhof, T. C., & Powell, C. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4517-09.2010 · Cited by 450 · see citing works

Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments

Etherton, M. R., Blaiss, C. A., Powell, C. M., & Südhof, T. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910297106 · Cited by 447 · see citing works

Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP

Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438 · see citing works

Smaller Dendritic Spines, Weaker Synaptic Transmission, but Enhanced Spatial Learning in Mice Lacking Shank1

Hung, A. Y., Futai, K., Sala, C., Valtschanoff, J. G., Ryu, J., Woodworth, M. A., Kidd, F. L., Sung, C. C., Miyakawa, T., Bear, M. F., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3032-07.2008 · Cited by 350 · see citing works

Children and adolescents with autism exhibit reduced MEG steady-state gamma responses

Wilson, T. W., Rojas, D. C., Reite, M. L., Teale, P. D., & Rogers, S. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.002 · Cited by 350 · see citing works

Linkage and association of the glutamate receptor 6 gene with autism

Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C., Leboyer, M., & Bourgeron, T. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000979 · Cited by 332 · see citing works

Piracetam: A Review of Pharmacological Properties and Clinical Uses

Winblad, B. G. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00268.x · Cited by 318 · see citing works

Validating γ oscillations and delayed auditory responses as translational biomarkers of autism

Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. L., & Siegel, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.031 · Cited by 314 · see citing works

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

de Vrij, F. M. S., Levenga, J., van der Linde, H. C., Koekkoek, S. K., De Zeeuw, C. I., Nelson, D. L., Oostra, B. A., & Willemsen, R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.002 · Cited by 313 · see citing works

The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders

Betancur, C., Sakurai, T., & Buxbaum, J. D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.04.003 · Cited by 298 · see citing works

Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons

Lauterborn, J. C., LYNCH, G. S., Vanderklish, P. W., Arai, A., & Gall, C. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00008.2000 · Cited by 291 · see citing works

Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid

Rinaldi, T., Kulangara, K., Antoniello, K., & Markram, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704391104 · Cited by 290 · see citing works

Excess of High Frequency Electroencephalogram Oscillations in Boys with Autism

Orekhova, E. V., Stroganova, T. A., Nygren, G., Tsetlin, M. M., Posikera, I. N., Gillberg, C., & Elam, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.029 · Cited by 286 · see citing works

Characterization of dFMR1, a Drosophila melanogaster Homolog of the Fragile X Mental Retardation Protein

Wan, L., Dockendorff, T. C., Jongens, T. A., & Dreyfuss, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8536-8547.2000 · Cited by 280 · see citing works

Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome

Dölen, G., & Bear, M. F. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.150722 · Cited by 278 · see citing works

Distinct Roles for the Kainate Receptor Subunits GluR5 and GluR6 in Kainate-Induced Hippocampal Gamma Oscillations

Fisahn, A., Contractor, A., Traub, R. D., Buhl, E. H., Heinemann, S. F., & McBain, C. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2973-04.2004 · Cited by 247 · see citing works

Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors

Nakamoto, M., Nalavadi, V., Epstein, M. P., Narayanan, U., Bassell, G. J., & Warren, S. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707484104 · Cited by 245 · see citing works

Drosophila Fragile X Protein, DFXR, Regulates Neuronal Morphology and Function in the Brain

Morales, J., Hiesinger, P. R., Schroeder, A. J., Kume, K., Verstreken, P., Jackson, F. R., Nelson, D. L., & Hassan, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00731-6 · Cited by 238 · see citing works

Association of Mouse Dlg4 (PSD-95) Gene Deletion and Human DLG4 Gene Variation With Phenotypes Relevant to Autism Spectrum Disorders and Williams' Syndrome

Feyder, M. J., Karlsson, R., Mathur, P., Lyman, M., Bock, R., Momenan, R., Munasinghe, J., Scattoni, M. L., Ihne, J. L., Camp, M., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10040484 · Cited by 233 · see citing works

Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability

Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007) · Journal of Child Neurology · doi:10.1177/0883073807302611 · Cited by 221 · see citing works

Sociability and motor functions in Shank1 mutant mice

Silverman, J. L., Turner, S. M., Barkan, C. L., Tolu, S. S., Saxena, R., Hung, A. Y., Sheng, M., & Crawley, J. N. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.026 · Cited by 218 · see citing works

Toward a developmental neurobiology of autism

Polleux, F., & Lauder, J. M. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20044 · Cited by 216 · see citing works

Decreased GABAA receptor expression in the seizure-prone fragile X mouse

Idrissi, A. E., Ding, X., Scalia, J., Trenkner, E., Brown, W. T., & Dobkin, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.087 · Cited by 210 · see citing works

Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder

King, B. H., WRIGHT, D. M., Handen, B. L., Sikich, L., Zimmerman, A. W., McMahon, W., Cantwell, E., Davanzo, P. A., Dourish, C. T., Dykens, E. M., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00010 · Cited by 197 · see citing works

The Female Urine Sniffing Test: A Novel Approach for Assessing Reward-Seeking Behavior in Rodents

Malkesman, O., Scattoni, M. L., Paredes, D., Tragon, T. R., Pearson, B. L., Shaltiel, G., Chen, G., Crawley, J. N., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.10.018 · Cited by 197 · see citing works

Development of a mouse test for repetitive, restricted behaviors: Relevance to autism

Moy, S. S., Nadler, J. J., Poe, M. D., Nonneman, R. J., Young, N. B., Koller, B. H., Crawley, J. N., Duncan, G. E., & Bodfish, J. W. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.029 · Cited by 195 · see citing works

Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function

Duncan, G. E., Moy, S. S., Perez, A., Eddy, D. M., Zinzow-Kramer, W. M., Lieberman, J. A., Snouwaert, J. N., & Koller, B. H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.008 · Cited by 194 · see citing works

Social behavior deficits in the Fmr1 mutant mouse

Mineur, Y. S., Huynh, L. X., & Crusio, W. E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.11.004 · Cited by 177 · see citing works

Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome.

McNaughton, C. H., Moon, J., Strawderman, M. S., Maclean, K. N., Evans, J., & Strupp, B. J. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.2.293 · Cited by 174 · see citing works

Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania

Shaltiel, G., Maeng, S., Malkesman, O., Pearson, B., Schloesser, R. J., Tragon, T., Rogawski, M., Gasior, M., Luckenbaugh, D., Chen, G., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.20 · Cited by 173 · see citing works

Group I Metabotropic Glutamate Receptor NMDA Receptor Coupling and Signaling Cascade Mediate Spinal Dorsal Horn NMDA Receptor 2B Tyrosine Phosphorylation Associated with Inflammatory Hyperalgesia

Guo, W., Wei, F., Zou, S., Robbins, M. T., Sugiyo, S., Ikeda, T., Tu, J.-C., Worley, P. F., Dubner, R. A., & Ren, K. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3422-04.2004 · Cited by 167 · see citing works

A retrospective study of memantine in children and adolescents with pervasive developmental disorders

Erickson, C. A., Posey, D. J., Stigler, K. A., Mullett, J. E., Katschke, A. R., & McDougle, C. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0518-9 · Cited by 159 · see citing works

The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature

Lodge, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.006 · Cited by 158 · see citing works

Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism

Rojas, D. C., Maharajh, K., Teale, P. D., & Rogers, S. J. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-66 · Cited by 158 · see citing works

Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome

Suvrathan, A., Hoeffer, C. A., Wong, H., Klann, E., & Chattarji, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002262107 · Cited by 137 · see citing works

Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome

Tucker, B., Richards, R. I., & Lardelli, M. T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl422 · Cited by 133 · see citing works

Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes

Bardoni, B., & Mandel, J. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00300-3 · Cited by 129 · see citing works

Mechanism-based approaches to treating fragile X

Dölen, G., Carpenter, R. L., Ocain, T. D., & Bear, M. F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.008 · Cited by 124 · see citing works

Animal Models of Obsessive-Compulsive Disorder: Rationale to Understanding Psychobiology and Pharmacology

Schaun Korff, A., & Harvey, B. H. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.007 · Cited by 123 · see citing works

The Role of Metabotropic Glutamate Receptor 5 in Learning and Memory Processes

Simonyi, Á., Schachtman, T. R., & Christoffersen, G. R. J. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.6.927927 · Cited by 112 · see citing works

Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice

Kolozsi, E., Mackenzie, R. N., Roullet, F. I., Decatanzaro, D., & Foster, J. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.021 · Cited by 110 · see citing works

The kainate receptor subunit GluR6 mediates metabotropic regulation of the slow and medium AHP currents in mouse hippocampal neurones

Fisahn, A., Heinemann, S. F., & McBain, C. J. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077412 · Cited by 108 · see citing works

Family‐based association study between autism and glutamate receptor 6 gene in Chinese Han trios

Mei, S., Liu, J., Jia, M. X., Yang, J. Z., Wu, S., Gong, X. H., Ling, Y., Ruan, Y., Yang, X., & Zhang, D. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30025 · Cited by 104 · see citing works

NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice

Eadie, B. D., Cushman, J. D., Kannangara, T. S., Fanselow, M. S., & Christie, B. R. (2010) · Hippocampus · doi:10.1002/hipo.20890 · Cited by 103 · see citing works

Generation and Characterization of Fmr1 Knockout Zebrafish

den Broeder, M. J., van der Linde, H., Brouwer, J. R., Oostra, B. A., Willemsen, R., & Ketting, R. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007910 · Cited by 103 · see citing works

Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome

Dahlhaus, R., & El-Husseini, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.019 · Cited by 102 · see citing works

Evidence for abnormal early development in a mouse model of Rett syndrome

Santos, M., Silva‐Fernandes, A., Oliveira, P., Sousa, N., & Maciel, P. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00258.x · Cited by 95 · see citing works

Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene.

Spencer, C. M., Graham, D. F., Yuva-Paylor, L. A., Nelson, D. L., & Paylor, R. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.3.710 · Cited by 91 · see citing works

Linkage and candidate gene studies of autism spectrum disorders in European populations

Holt, R., Barnby, G., Maestrini, E., Bacchelli, E., Brocklebank, D., Sousa, I., Mulder, E. J., Kantojärvi, K., Järvelä, I. E., Klauck, S. M., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.69 · Cited by 85 · see citing works

Activity-dependent Regulation of Synapse and Dendritic Spine Morphology in Developing Barrel Cortex Requires Phospholipase C- 1 Signalling

Spires‐Jones, T. L. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh141 · Cited by 78 · see citing works

Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes

Musumeci, S. A., Calabrese, G., Bonaccorso, C. M., D'Antoni, S., Brouwer, J. R., Bakker, C. E., Elia, M., Ferri, R., Nelson, D. L., Oostra, B. A., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.007 · Cited by 70 · see citing works

A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder

Akhondzadeh, S., Tajdar, H., Mohammadi, M.-R., Mohammadi, M., Nouroozinejad, G.-H., Shabstari, O. L., & Ghelichnia, H. A. (2007) · Child Psychiatry & Human Development · doi:10.1007/s10578-007-0084-3 · Cited by 66 · see citing works

Regulation of the Postsynaptic Cytoskeleton: Roles in Development, Plasticity, and Disorders

Svitkina, T., Lin, W., Webb, D. J., Yasuda, R., Wayman, G. A., Aelst, L. V., & Soderling, S. H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4276-10.2010 · Cited by 63 · see citing works

Metabotropic actions of kainate receptors in the CNS

Moreno, A. R., & Sihra, T. S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04924.x · Cited by 60 · see citing works

Glutamate Antagonists Seem to be Slightly Effective in Psychopharmacologic Treatment of Autism

Niederhofer, H. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000270082.30500.69 · Cited by 51 · see citing works

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia

Ramsey, A. J. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17906-2 · Cited by 49 · see citing works

Family-based association study between GRIK2 polymorphisms and autism spectrum disorders in the Korean trios

Kim, S. A., Kim, J. H., Park, M., Cho, I. H., & Yoo, H. J. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.03.002 · Cited by 49 · see citing works

Roles of distinct glutamate receptors in induction of anti‐Hebbian long‐term potentiation

Kullmann, D. M., & Lamsa, K. P. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.148064 · Cited by 48 · see citing works

Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse

Meredith, R. M., de Jong, R., & Mansvelder, H. D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.026 · Cited by 35 · see citing works

Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain

Maliszewska‐Cyna, E., Bawa, D., & Eubanks, J. H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.065 · Cited by 33 · see citing works

Receptor‐associated proteins and synaptic plasticity

Bruneau, E., Esteban, J. A., & Akaaboune, M. (2008) · The FASEB Journal · doi:10.1096/fj.08-107946 · Cited by 32 · see citing works

Functional Significance of the Kainate Receptor GluR6(M836I) Mutation that is Linked to Autism

Strutz-Seebohm, N., Korniychuk, G., Schwarz, R., Baltaev, R., Ureche, O., Mack, A., Ma, Z.-L., Hollmann, M., Lang, F., & Seebohm, G. (2006) · Cellular Physiology and Biochemistry · doi:10.1159/000097675 · Cited by 32 · see citing works

MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.

Westmark, C. J., Westmark, P. R., & Malter, J. S. (2009) · PubMed Central · Cited by 29 · see citing works

RNA Targets of the Fragile X Protein

Kaytor, M. D., & Orr, H. T. (2001) · Cell · doi:10.1016/s0092-8674(01)00590-6 · Cited by 29 · see citing works

Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: Theoretical comment on McNaughton et al. (2008).

Brodkin, E. S. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.2.483 · Cited by 23 · see citing works

Consensus Paper: Pathological Role of the Cerebellum in Autism

Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723 · see citing works

Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators

Duffney, L. J., Zhong, P., Wei, J., Matas, E., Cheng, J., Qin, L., Ma, K., Dietz, D. M., Kajiwara, Y., Buxbaum, J. D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.064 · Cited by 281 · see citing works

Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition

Qin, L., Ma, K., Wang, Z.-J., Hu, Z., Matas, E., Wei, J., & Yan, Z. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0110-8 · Cited by 240 · see citing works

The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment

Rojas, D. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1216-0 · Cited by 191 · see citing works

mGluR5-Antagonist Mediated Reversal of Elevated Stereotyped, Repetitive Behaviors in the VPA Model of Autism

Mehta, M. V., Gandal, M. J., & Siegel, S. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026077 · Cited by 182 · see citing works

Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system

Baxter, P. S., Bell, K. F. S., Hasel, P., Kaindl, A. M., Fricker, M., Thomson, D., Cregan, S. P., Gillingwater, T. H., & Hardingham, G. E. (2015) · Nature Communications · doi:10.1038/ncomms7761 · Cited by 139 · see citing works

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

Asadabadi, M., Mohammadi, M.-R., Ghanizadeh, A. J., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., & Akhondzadeh, S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2796-8 · Cited by 143 · see citing works

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

Ghaleiha, A., Asadabadi, M., Mohammadi, M.-R., Shahei, M., Tabrizi, M. H., Hajiaghaee, R., Hassanzadeh, E., & Akhondzadeh, S. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000880 · Cited by 134 · see citing works

Autistic-Like Syndrome in Mu Opioid Receptor Null Mice is Relieved by Facilitated mGluR4 Activity

Becker, J. A. J., Clesse, D., Spiegelhalter, C., Schwab, Y., Merrer, J. L., & Kieffer, B. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.59 · Cited by 123 · see citing works

Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

Gandal, M. J., Anderson, R. L., Billingslea, E. N., Carlson, G. C., Roberts, T. P. L., & Siegel, S. J. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00816.x · Cited by 120 · see citing works

Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies

Shimamoto, C., Ohnishi, T., Maekawa, M., Watanabe, A., Ohba, H., Arai, R., Iwayama, Y., Hisano, Y., Toyota, T., Toyoshima, M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu369 · Cited by 116 · see citing works

Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism

Duffney, L. J., Wei, J., Cheng, J., Liu, W., Smith, K. R., Kittler, J. T., & Yan, Z. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1175-13.2013 · Cited by 115 · see citing works

Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission

Montanari, M., Martella, G., Bonsi, P., & Meringolo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073861 · Cited by 105 · see citing works

Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders

Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 94 · see citing works

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications

Willard, S. S., & Koochekpour, S. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6475 · Cited by 86 · see citing works

Acupuncture for autism spectrum disorders (ASD)

Cheuk, D. K., Wong, V. C. N., & Chen, W. X. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007849.pub2 · Cited by 81 · see citing works

Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects

Coccaro, E. F., Lee, R., & Vezina, P. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.001 · Cited by 72 · see citing works

Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism

Ma, K., Qin, L., Matas, E., Duffney, L. J., Liu, A., & Yan, Z. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0073-1 · Cited by 71 · see citing works

Psychopharmacological Interventions in Autism Spectrum Disorder

Politte, L. C., Henry, C. A., & McDougle, C. J. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000030 · Cited by 73 · see citing works

Glutamate, Glutamine and GABA Levels in Rat Brain Measured Using MRS, HPLC and NMR Methods in Study of Two Models of Autism

Ziemińska, E., Toczyłowska, B., Diamandakis, D., Hilgier, W., Filipkowski, R. K., Polowy, R., Orzel, J., Górka, M., & Łazarewicz, J. W. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00418 · Cited by 67 · see citing works

Sociocommunicative and Sensorimotor Impairments in Male P2X4-Deficient Mice

Wyatt, L. R., Godar, S. C., Khoja, S., Jakowec, M. W., Alkana, R. L., Bortolato, M., & Davies, D. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.98 · Cited by 65 · see citing works

Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders

Yoo, H. J., Cho, I. H., Park, M., Yang, S. Y., & Kim, S. A. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.061 · Cited by 63 · see citing works

Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder

Kolodny, T., Schallmo, M., Gerdts, J. A., Edden, R. A. E., Bernier, R., & Murray, S. O. (2020) · Autism Research · doi:10.1002/aur.2300 · Cited by 59 · see citing works

Double Dissociation of the Roles of Metabotropic Glutamate Receptor 5 and Oxytocin Receptor in Discrete Social Behaviors

Mesic, I., Guzmán, Y. F., Guedea, A. L., Jovasevic, V., Corcoran, K. A., Leaderbrand, K., Nishimori, K., Contractor, A., & Radulović, J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.81 · Cited by 64 · see citing works

Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research

Canitano, R., & Palumbi, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753274 · Cited by 60 · see citing works

Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model

Matas, E., Maïsterrena, A., Thabault, M., Balado, É., Francheteau, M., Balbous, A., Galvan, L., & Jaber, M. (2021) · Molecular Autism · doi:10.1186/s13229-020-00412-8 · Cited by 58 · see citing works

Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications

Chana, G., Laskaris, L., Pantelis, C., Gillett, P., Testa, R., Zantomio, D., Burrows, E. L., Hannan, A. J., Everall, I., & Skafidas, E. S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.009 · Cited by 56 · see citing works

Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies

Eltokhi, A., Santuy, A., Merchán-Pérez, Á., & Sprengel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010059 · Cited by 52 · see citing works

Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds

Drapier, T., Geubelle, P., Bouckaert, C., Nielsen, L., Laulumaa, S., Goffin, E., Dilly, S., Francotte, P., Hanson, J., Pochet, L., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00250 · Cited by 51 · see citing works

Deep brain stimulation for severe autism: from pathophysiology to procedure

Sinha, S. R., McGovern, R. A., & Sheth, S. A. (2015) · Neurosurgical FOCUS · doi:10.3171/2015.3.focus1548 · Cited by 51 · see citing works

Impaired hippocampus-dependent spatial flexibility and sociability represent autism-like phenotypes in GluK2 mice

Micheau, J., Vimeney, A., Normand, E., Mulle, C., & Riedel, G. (2014) · Hippocampus · doi:10.1002/hipo.22290 · Cited by 43 · see citing works

Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD

Zantomio, D., Chana, G., Laskaris, L., Testa, R., Everall, I., Pantelis, C., & Skafidas, E. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.006 · Cited by 45 · see citing works

Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats

Abhishek, M., Singla, R., Kumar, R., Rupa, J., Sarma, P., Gurjeet, K., Raj, S. A., Prajapat, M., Alka, B., Ramprasad, P., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115199 · Cited by 44 · see citing works

Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder

Porton, B., Greenberg, B. D., Askland, K., Serra, L. M., Gesmonde, J., Rudnick, G., Rasmussen, S. A., & Kao, H.-T. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.35 · Cited by 36 · see citing works

Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology

Port, R. G., Gandal, M. J., Roberts, T. P. L., Siegel, S. J., & Carlson, G. C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00414 · Cited by 38 · see citing works

Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study

Wink, L. K., Reisinger, D. L., Horn, P. S., Shaffer, R. C., O’Brien, K., Schmitt, L., Dominick, K. C., Pedapati, E. V., & Erickson, C. A. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04542-z · Cited by 39 · see citing works

Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy

Harms, J. E., Benveniste, M., Maclean, J. K. F., Partin, K. M., & Jamieson, C. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.008 · Cited by 37 · see citing works

Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder

Khoja, S., Haile, M. T., & Chen, L. Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1125087 · Cited by 34 · see citing works

Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: Evidence from sleep–wake EEG in rodents

Ahnaou, A., Ver Donck, L., & Drinkenburg, W. H. I. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.003 · Cited by 31 · see citing works

Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies

Toczyłowska, B., Ziemińska, E., Senator, P., & Łazarewicz, J. W. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01935-0 · Cited by 33 · see citing works

Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder

Frye, R. E. (2014) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s39595 · Cited by 33 · see citing works

The State of the Dopaminergic and Glutamatergic Systems in the Valproic Acid Mouse Model of Autism Spectrum Disorder

Maïsterrena, A., Matas, E., Mirfendereski, H., Balbous, A., Marchand, S., & Jaber, M. (2022) · Biomolecules · doi:10.3390/biom12111691 · Cited by 32 · see citing works

A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions

Majhi, S., Kumar, S., & Singh, L. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220428134802 · Cited by 32 · see citing works

Glutamatergic candidate genes in autism spectrum disorder: an overview

Chiocchetti, A. G., Bour, H. S., & Freitag, C. M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1161-y · Cited by 30 · see citing works

Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: A screening test

Lenart, J., Augustyniak, J., Łazarewicz, J. W., & Ziemińska, E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152500 · Cited by 31 · see citing works

A Christianson syndrome-linked deletion mutation (∆287ES288) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death

Ilie, A., Gao, A. Y. L., Reid, J., Boucher, A., McEwan, C., Barrière, H., Lukács, G. L., McKinney, R. A., & Orlowski, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0129-9 · Cited by 29 · see citing works

Relationship between the effect of polyunsaturated fatty acids (PUFAs) on brain plasticity and the improvement on cognition and behavior in individuals with autism spectrum disorder

Barón-Mendoza, I., & González-Arenas, A. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1755793 · Cited by 28 · see citing works

Valproic Acid in Autism Spectrum Disorder: From an Environmental Risk Factor to a Reliable Animal Model

Gottfried, C., Bambini-Júnior, V., Baronio, D., Zanatta, G., Bristot, R., Vaccaro, T. D. S., & Riesgo, R. D. S. (2013) · InTech eBooks · doi:10.5772/54824 · Cited by 28 · see citing works

AMPA Receptor Function in Hypothalamic Synapses

Royo, M., Aznar-Escolano, B., Madrigal, M. P., & Jurado, S. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.833449 · Cited by 29 · see citing works

Decreased plasma agmatine levels in autistic subjects

Esnafoğlu, E., & İrende, İ. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1836-2 · Cited by 26 · see citing works

Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder

Lee, Y. J., Oh, S. H., Park, C., Hong, M., Lee, A. R., Yoo, H. J., Shin, C. Y., Cheon, K.-A. A., & Bahn, G. H. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.19 · Cited by 25 · see citing works

Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning

Sun, X., Pinacho, R., Saia, G., Punko, D., Meana, J. J., Ramos, B., & Gill, G. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22212 · Cited by 23 · see citing works

Impaired Object Recognition but Normal Social Behavior and Ultrasonic Communication in Cofilin1 Mutant Mice

Sungur, A. Ö., Stemmler, L., Wöhr, M., & Rust, M. B. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00025 · Cited by 21 · see citing works

Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder

Shuid, A. N., Jayusman, P. A., Shuid, N., Ismail, J., Nor, N. K., & Mohamed, I. N. (2020) · Brain Sciences · doi:10.3390/brainsci10050309 · Cited by 20 · see citing works

Ketamine administration in early postnatal life as a tool for mimicking Autism Spectrum Disorders core symptoms

Bové, M., Schiavone, S., Tucci, P., Sikora, V., Dimonte, S., Colia, A. L., Morgese, M. G., & Trabace, L. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110560 · Cited by 20 · see citing works

Neuromagnetic Beta-Band Oscillations during Motor Imitation in Youth with Autism

Buard, I., Kronberg, E., Steinmetz, S. E., Hepburn, S., & Rojas, D. C. (2018) · Autism Research and Treatment · doi:10.1155/2018/9035793 · Cited by 17 · see citing works

Autism spectrum disorder and various mechanisms behind it

Rajabi, P., Noori, A. S., & Sargolzaei, J. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173887 · Cited by 16 · see citing works

Genetically modified mice related to schizophrenia and other psychoses: Seeking phenotypic insights into the pathobiology and treatment of negative symptoms

O’Tuathaigh, C. M. P., Desbonnet, L., & Waddington, J. L. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.08.009 · Cited by 14 · see citing works

Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains

Mishra, A., Singla, R., Kumar, R., Sharma, A. R., Joshi, R., Sarma, P., Kaur, G., Prajapat, M., Bhatia, A., & Medhi, B. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00270 · Cited by 14 · see citing works

Prenatal Exposure to Valproate in Animals and Autism

Bambini-Júnior, V., Baronio, D., MacKenzie, J., Zanatta, G., Riesgo, R. D. S., & Gottfried, C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_108 · Cited by 14 · see citing works

Glutamatergic agents in Autism Spectrum Disorders: Current trends

Canitano, R., & Scandurra, V. (2014) · Research in Autism · doi:10.1016/j.rasd.2013.12.009 · Cited by 14 · see citing works

Crmp4-KO Mice as an Animal Model for Investigating Certain Phenotypes of Autism Spectrum Disorders

Ohtani‐Kaneko, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102485 · Cited by 13 · see citing works

Reduced visual cortical plasticity in autism spectrum disorder

Ellis, R. E., Milne, E., & Levita, L. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.01.019 · Cited by 12 · see citing works

A blueprint for research on Shankopathies: A view from research on autism spectrum disorder

Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 12 · see citing works

Mitochondrial dysfunction reveals H2S-mediated synaptic sulfhydration as a potential mechanism for autism-associated social defects

Xian, P., Wang, M., Xie, R., Ma, H., Zheng, W., Kang, J., Chen, Y., Liu, H., Dong, S., Liu, H., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.08.003 · Cited by 11 · see citing works

Abnormal sensory perception masks behavioral performance of Grin1 knockdown mice

Lipina, T. V., Men, X., Blundell, M., Salahpour, A., & Ramsey, A. J. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12825 · Cited by 10 · see citing works

Acetylcysteine for treatment of autism spectrum disorder symptoms

Stutzman, D. L., & Dopheide, J. A. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150072 · Cited by 10 · see citing works

Crystal Structures of Potent Dimeric Positive Allosteric Modulators at the Ligand-Binding Domain of the GluA2 Receptor

Laulumaa, S., Hansen, K. V., Masternak, M., Drapier, T., Francotte, P., Pirotte, B., Frydenvang, K., & Kastrup, J. S. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00369 · Cited by 10 · see citing works

Effects of lurasidone on ketamine-induced joint visual attention dysfunction as a possible disease model of autism spectrum disorders in common marmosets

Nakako, T., Murai, T., Ikejiri, M., Hashimoto, T., Kotani, M., Matsumoto, K., Manabe, S., Ogi, Y., Konoike, N., Nakamura, K., et al. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.032 · Cited by 9 · see citing works

Altered Expression and In Vivo Activity of mGlu5 Variant a Receptors in the Striatum of BTBR Mice: Novel Insights Into the Pathophysiology of Adult Idiopathic Forms of Autism Spectrum Disorders

Matrisciano, F., Locci, V., Dong, E., Nicoletti, F., Guidotti, A., & Grayson, D. R. (2022) · Current Neuropharmacology · doi:10.2174/1567202619999220209112609 · Cited by 9 · see citing works

Chemical Modulators for Targeting Autism Spectrum Disorders: From Bench to Clinic

Lim, S., & Lee, S. (2022) · Molecules · doi:10.3390/molecules27165088 · Cited by 8 · see citing works

A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder

Purushotham, S. S., Reddy, N. M. N., D’Souza, M. N., Choudhury, N. R., Ganguly, A., Gopalakrishna, N., Muddashetty, R. S., & Clement, J. P. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06448-x · Cited by 8 · see citing works

Lack of serum antineuronal antibodies in children with autism

Bayram, A. K., Kardaş, F., Demi̇rci̇, E., Gökahmetoğlu, S., Özmen, S., Canpolat, M., Öztop, D. B., Kumandaş, S., Gümüş, H., & Per, H. (2016) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2016_015 · Cited by 7 · see citing works

Polymorphisms of Ionotropic Glutamate Receptor-Related Genes and the Risk of Autism Spectrum Disorder in a Chinese Population

Xie, X., Hou, F., Li, L., Chen, Y., Liu, L., Luo, X., Gu, H., Li, X., Zhang, J., Gong, J., et al. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.02.26.3 · Cited by 5 · see citing works

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report

Olivola, M., Arienti, V., Bassetti, N., Civardi, S. C., & Brondino, N. (2022) · EXCLI journal · doi:10.17179/excli2022-4694 · Cited by 5 · see citing works

Evaluation of the protective effect of capric acid on behavioral and biochemical alterations in valproic acid-induced model of autism

Shekhar, N., & Thakur, A. K. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105767 · Cited by 4 · see citing works

C1q/TNF-related protein-1: Potential biomarker for early diagnosis of autism spectrum disorder

Raeisy, H., Bayati, P., Noorbakhsh, F., Shooshtari, M. H., Ardebili, M. E., Shekarabi, M., & Mojtabavi, N. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221079471 · Cited by 4 · see citing works

Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum

Kubera, C., Hernandez, A. L., Heng, V., & Bordey, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.064 · Cited by 4 · see citing works

Effects of environmental enrichment and sexual dimorphism on the expression of cerebellar receptors in C57BL/6 and BTBR + Itpr3tf/J mice

Reyna, D. M., Denes, J. M., & Santamarı́a, F. (2022) · BMC Research Notes · doi:10.1186/s13104-022-06062-8 · Cited by 4 · see citing works

Fetal valproate syndrome as an experimental model of autism

Малышев, А. В., Abbasova, K., Averina, O. A., Solovieva, L. N., Gedzun, V. R., Gulyaev, M. V., & Дубынин, В. А. (2015) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392515030074 · Cited by 4 · see citing works

Reduced effect of stimulation of AMPA receptors on cerebral O2 consumption in a rat model of autism

Weiss, H. R., Liu, X., Grewal, P., & CHI, O. Z. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.014 · Cited by 5 · see citing works

Inhibitory and Excitatory Systems in Autism Spectrum Disorders

Blatt, G. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00024-7 · Cited by 4 · see citing works

Neural Targets in the Study and Treatment of Social Cognition in Autism Spectrum Disorder

Vahabzadeh, A. B. N., Landino, S. M., Finger, B. C., Carlezon, W. A., & McDougle, C. J. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_11 · Cited by 3 · see citing works

GABAergic regulation of auditory repetition suppression in adults with and without Autism Spectrum DisorderPreprint

Huang, Q., Velthuis, H., Pereira, A. C., Ahmad, J., Cooke, S. F., Ellis, C. L., Ponteduro, F. M., Puts, N. A. J., Dimitrov, M., Batallé, D., et al. (2023) · medRxiv · doi:10.1101/2023.02.15.23285928 · Cited by 2 · see citing works

The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder

Bonetti, M., Borsani, E., & Bonomini, F. (2024) · Cells · doi:10.3390/cells13242036 · Cited by 1 · see citing works

Decoding Autism: The Role of Synaptic Dysfunction in Neurodevelopment

Cetinkaya, F. B., Bandırmalı, D., & Akay, G. G. (2025) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.65092/autfm.1715662 · Cited by 1 · see citing works

Effects of Walnut and Pumpkin on Selective Neurophenotypes of Autism Spectrum Disorders: A Case Study

El-Ansary, A. K., & AL-Ayadhi, L. Y. (2023) · Nutrients · doi:10.3390/nu15214564 · Cited by 1 · see citing works

8p21.3 deletions are rare causes of non-syndromic autism spectrum disorder

Cosemans, N., Maljaars, J., Vogels, A., Holvoet, M., Devriendt, K., Steyaert, J. G., Bogaert, K. V. D., Noens, I. L. J., & Peeters, H. (2021) · Neurogenetics · doi:10.1007/s10048-021-00635-8 · Cited by 1 · see citing works

schizophrenia and autism spectrum disorder and mouse behavioral studies

Shimamoto, C., Ohnishi, T., Maekawa, M., Watanabe, A., Ohba, H., Arai, R., Iwayama, Y., Hisano, Y., Toyoshima, M., Suzuki, K., et al. (2014)

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic

Willard, I. S., & Koochekpour, S. (2013)

Deep brain stimulation for severe autism: from pathophysiology to procedure

Wood, R. J. (2015)

Αιτιολογικοί παράγοντες των διαταραχών αυτιστικού φάσματος(ΔΑΦ)

Αντωνίου, Α. Σ., & Daliana, N. (2017) · Πανελλήνιο Συνέδριο Επιστημών Εκπαίδευσης · doi:10.12681/edusc.836

Lack of correlation between phonetic magnetic mismatch field and plasma d-serine levels in humans

Suga, M., Kawakubo, Y., Nishimura, Y., Hashimoto, K., Yumoto, M., & Kasai, K. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.04.603

Biometal homeostasis as a therapeutic strategy in autism spectrum disorders

Grabrucker, A. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821132-8.00013-6

Effects of environmental enrichment and sexual dimorphism on the expression of cerebellar receptors in C57BL/6 and BTBR +Itpr3tf/J micePreprint

Reyna, D. M., Denes, J. M., & Santamarı́a, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1140363/v1

Novel Approaches for Treating Pediatric Psychiatric Disorders

Prasad, S., & Cook, E. H. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0067

À la découverte de l'autisme

Briault, S., & Hébert, B. (2020) · Dunod eBooks · doi:10.3917/dunod.yvon.2020.01.0058

À la découverte de l'autisme

Briault, S., & Hébert, B. (2014) · Dunod eBooks · doi:10.3917/dunod.yvon.2014.01.0058

Additional file 1 of Effects of environmental enrichment and sexual dimorphism on the expression of cerebellar receptors in C57BL/6 and BTBR + Itpr3tf/J mice

Reyna, D. M., Manzo Denes, J., & Santamarı́a, F. (2022) · Figshare · doi:10.6084/m9.figshare.19766346

Rôle des récepteurs Kaïnate dans la physiopathologie de l'épilepsie du lobe temporal

Peret, A. (2014) · theses.fr (ABES) · doi:10.70675/b757f254zaebaz4ba6zb3a9z456029671aba

Therapeutic potential of glutamatergic N-methyl-D-aspartate (NMDA) receptors-mediated molecules for autism spectrum disorders

(2015) · Neurotransmitter · doi:10.14800/nt.297

Glutamatergic agents in Autism Spectrum Disorders: Current trends

Canitano, R., & Scandurra, V. (2014) · Research in Autism · doi:10.1016/j.rasd.2013.12.009 · Cited by 14 · see citing works

Genetics of glutamate and its receptors in autism spectrum disorder

Nisar, S., Bhat, A. A., Masoodi, T., Hashem, S., Akhtar, S., Ali, T. A., Amjad, S., Chawla, S., Bagga, P., Frenneaux, M. P., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01506-w · Cited by 173 · see citing works

Unraveling mGluR5 dysfunction in autism spectrum disorder: a multi-level analysis of genetic, molecular, and neurobiological mechanisms

Dhungel, A., & Bora, R. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03116-0

Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets

Yang, P., & Chang, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612819666140110120725 · Cited by 33 · see citing works